Bigelow Investment Advisors LLC Has $2.85 Million Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Bigelow Investment Advisors LLC lowered its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 1.8% during the 4th quarter, Holdings Channel.com reports. The firm owned 5,404 shares of the healthcare conglomerate’s stock after selling 98 shares during the quarter. UnitedHealth Group accounts for approximately 1.5% of Bigelow Investment Advisors LLC’s portfolio, making the stock its 13th biggest position. Bigelow Investment Advisors LLC’s holdings in UnitedHealth Group were worth $2,845,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in UNH. Richelieu Gestion SA bought a new stake in shares of UnitedHealth Group during the fourth quarter worth about $26,000. Robbins Farley bought a new stake in UnitedHealth Group in the 3rd quarter worth about $25,000. CGC Financial Services LLC grew its position in UnitedHealth Group by 1,000.0% in the 4th quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after purchasing an additional 50 shares in the last quarter. NewSquare Capital LLC grew its position in UnitedHealth Group by 340.0% in the 3rd quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock worth $33,000 after purchasing an additional 51 shares in the last quarter. Finally, LFA Lugano Financial Advisors SA grew its position in UnitedHealth Group by 148.1% in the 4th quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock worth $35,000 after purchasing an additional 40 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Trading Up 1.6 %

Shares of NYSE:UNH traded up $7.95 on Friday, hitting $501.13. The company had a trading volume of 6,585,712 shares, compared to its average volume of 4,551,375. The firm’s 50-day simple moving average is $488.97 and its two-hundred day simple moving average is $515.22. The firm has a market capitalization of $462.01 billion, a price-to-earnings ratio of 30.63, a P/E/G ratio of 1.31 and a beta of 0.54. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $554.70. The company has a quick ratio of 0.79, a current ratio of 0.85 and a debt-to-equity ratio of 0.69.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.63 by $0.28. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The company had revenue of $99.80 billion for the quarter, compared to analysts’ expectations of $99.23 billion. During the same quarter last year, the company posted $6.26 earnings per share. The firm’s quarterly revenue was up 8.6% on a year-over-year basis. Equities analysts anticipate that UnitedHealth Group Incorporated will post 27.74 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Investors of record on Monday, March 11th were issued a $1.88 dividend. This represents a $7.52 annualized dividend and a yield of 1.50%. The ex-dividend date was Friday, March 8th. UnitedHealth Group’s dividend payout ratio is currently 45.97%.

Insider Transactions at UnitedHealth Group

In other news, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the transaction, the chief accounting officer now owns 32,289 shares in the company, valued at approximately $16,977,233.31. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. In other news, CAO Thomas E. Roos sold 858 shares of the firm’s stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the sale, the chief accounting officer now directly owns 32,289 shares in the company, valued at approximately $16,977,233.31. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction on Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the transaction, the executive vice president now owns 9,364 shares of the company’s stock, valued at approximately $4,527,306.72. The disclosure for this sale can be found here. Corporate insiders own 0.35% of the company’s stock.

Wall Street Analysts Forecast Growth

UNH has been the topic of a number of research analyst reports. HSBC upgraded shares of UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $460.00 target price on the stock in a research note on Thursday, April 4th. Wells Fargo & Company dropped their price target on shares of UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating on the stock in a research note on Monday, April 8th. Oppenheimer restated an “outperform” rating and set a $610.00 price target on shares of UnitedHealth Group in a research note on Wednesday, January 17th. Royal Bank of Canada dropped their price target on shares of UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating on the stock in a research note on Wednesday. Finally, StockNews.com cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Thursday. Four equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $570.05.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.